Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ProMIS Neurosciences

ProMIS Neurosciences
2004 FOUNDED
PUBLIC STATUS
1-10 EMPLOYEES
PMN STOCK SYMBOL
$0.09 SHARE PRICE (As of Thursday Closing)
Description

ProMIS Neurosciences Inc is a biotech company. It is engaged in discovering and developing precision medicine therapeutics for the effective treatment of neurodegenerative diseases, in particular, Alzheimer's disease, amyotrophic lateral sclerosis (ALS), and Parkinson's disease (PD).

Formerly Known As
Amorfix Life Sciences
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
TSE
Primary Office
  • 1920 Yonge Street
  • Suite 200
  • Toronto, Ontario M4S 3E2
  • Canada
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ProMIS Neurosciences’s full profile, request a free trial.

ProMIS Neurosciences Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.07 - $0.24 $24.9M $0.09 -$0.02 238K 282M

ProMIS Neurosciences Financials Summary

In Thousands,
USD
TTM
31-Dec-2019
FY 2019
31-Dec-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
Enterprise Value 35,541 35,541 45,296 32,340
Revenue 1 1 1 8
EBITDA (5,565) (5,565) (7,837) (4,627)
Net Income (5,572) (5,572) (7,842) (4,637)
Total Assets 1,587 1,587 2,178 1,726
Total Debt 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ProMIS Neurosciences Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore ProMIS Neurosciences‘s full profile, request access.

Request full access to PitchBook

ProMIS Neurosciences Competitors (27)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
EIP Pharma Venture Capital-Backed Cambridge, MA 0 000.00 0000000000 0 000.00
0000 Venture Capital-Backed San Diego, CA 00 00.000 00000 00000
000000 0000 000000 Formerly PE-Backed New York, NY 00 000.00 000000 - 000 000.00
00000000 000000000 Angel-Backed Cambridge, MA 0 00.000 0000000000 0 00.000
000000 00000000000 Formerly VC-backed San Diego, CA 000 00000 000000&0
To view this company’s complete list of competitors, request access »

ProMIS Neurosciences Executive Team (7)

Name Title Board
Seat
Contact
Info
Elliot Goldstein MD Chief Executive Officer & Board Member
Daniel Geffken Chief Financial Officer, Finance
Neil Cashman Chief Scientific Officer & Founder
Steven Plotkin Ph.D Chief Physics Officer
Johanne Kaplan Ph.D Executive

1 Former Executive

You’re viewing 5 of 7 executives. Get the full list »

ProMIS Neurosciences Board Members (3)

Name Representing Role Since Contact
Info
Elliot Goldstein MD ProMIS Neurosciences Chief Executive Officer & Board Member 000 0000
Eugene Williams ProMIS Neurosciences Chairman & Board Member 000 0000
Johannes Roth Self Board Member 000 0000